Search research articles
Contact Us
Filters
Showing results (51-60 of 167) with videos related to
Page
of 17
Sort By:
American Journal of Clinical Oncology
|
December 17, 2015
Immunogenicity of Influenza Vaccination in Patients With Cancer
Saiama N Waqar, Leigh Boehmer, Daniel Morgensztern, et al.
Investigational New Drugs
|
August 11, 2010
A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors
Andrea Wang-Gillam, Susanne M Arnold, Ronald M Bukowski, et al.
Journal of Geriatric Oncology
|
March 8, 2019
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial
Teresa Macarulla, Jean-Frédéric Blanc, Andrea Wang-Gillam, et al.
Frontiers in Oncology
|
December 9, 2021
Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway
Yao Lu, Dao Xin, Lulu Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 25, 2013
Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer
Margaret A Tempero, David Klimstra, Jordan Berlin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 21, 2012
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
Eugene V McCloskey, Helena Johansson, Anders Oden, et al.
Cancer Research
|
January 25, 2018
Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
Daoxiang Zhang, Lin Li, Hongmei Jiang, et al.
Journal of Gastrointestinal Oncology
|
June 12, 2019
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer
Manik Amin, Monica Desai, Kathryn Trinkaus, et al.
Journal of Clinical Pharmacology
|
February 19, 2025
Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR -1, -2, and -3, in Patients with Refractory Metastatic Colorectal Cancer
Xiaofei Zhou, Xiaoyan Yang, Boris Grinshpun, et al.
Frontiers in Oncology
|
February 26, 2024
<i>ERBB2</i> (HER2) amplifications and co-occurring <i>KRAS</i> alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 167) with videos related to
Sort By:
Page
of 17
American Journal of Clinical Oncology
|
December 17, 2015
Immunogenicity of Influenza Vaccination in Patients With Cancer
Saiama N Waqar, Leigh Boehmer, Daniel Morgensztern, et al.
Investigational New Drugs
|
August 11, 2010
A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors
Andrea Wang-Gillam, Susanne M Arnold, Ronald M Bukowski, et al.
Journal of Geriatric Oncology
|
March 8, 2019
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial
Teresa Macarulla, Jean-Frédéric Blanc, Andrea Wang-Gillam, et al.
Frontiers in Oncology
|
December 9, 2021
Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway
Yao Lu, Dao Xin, Lulu Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 25, 2013
Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer
Margaret A Tempero, David Klimstra, Jordan Berlin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 21, 2012
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
Eugene V McCloskey, Helena Johansson, Anders Oden, et al.
Cancer Research
|
January 25, 2018
Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
Daoxiang Zhang, Lin Li, Hongmei Jiang, et al.
Journal of Gastrointestinal Oncology
|
June 12, 2019
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer
Manik Amin, Monica Desai, Kathryn Trinkaus, et al.
Journal of Clinical Pharmacology
|
February 19, 2025
Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR -1, -2, and -3, in Patients with Refractory Metastatic Colorectal Cancer
Xiaofei Zhou, Xiaoyan Yang, Boris Grinshpun, et al.
Frontiers in Oncology
|
February 26, 2024
<i>ERBB2</i> (HER2) amplifications and co-occurring <i>KRAS</i> alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
Page
of 17